Interpace Biosciences, Inc. IDXG
7.00 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
6.20 Day range 6.20
0.806 52-week range 7.80
- YTD
- +469.11%
- 1 year
- +614.29%
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 31.84M | 33.12M | 32.40M | 24.22M | 21.90M | |
| 18.23M | 18.80M | 10.72M | 8.33M | 11.70M | |
| -3.84M | -6.67M | -26.55M | -26.48M | -11.11M | |
| -21.96M | -14.94M | -26.45M | -26.74M | -12.70M | |
| -5.18 | -3.61 | -7.32 | -7.25 | -4.52 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 4.83M | 2.92M | 3.37M | 2.32M | 6.07M | |
| 15.98M | 38.43M | 45.68M | 51.54M | 31.13M | |
| 32.52M | 34.31M | 28.23M | 29.85M | 15.68M | |
| 15.51M | 9.96M | 3.54M | 5.59M | 0 | |
| -63.07M | -42.42M | -29.08M | -4.48M | 15.45M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -7.69M | -8.72M | -13.98M | -18.96M | -8.67M | |
| 6.21M | -315.00K | -1.57M | -13.95M | -449.00K | |
| 3.00M | 8.98M | 16.61M | 29.16M | -9.00K | |
| -322.00K | -315.00K | -1.57M | -118.00K | -449.00K | |
| 1.51M | -58.00K | 1.05M | -3.75M | -9.13M |